
Shirish Gundopant Belapure
About Shirish Gundopant Belapure
Data last updated:
Shirish Gundopant Belapure is a Director at Jubilant Pharmova Limited (since 2023), Director at Innova Captab Limited (since 2022) and Director at Corona Remedies Limited (since 2025), and holds 6 more current directorships. The companies operate in Pharma and Chemicals. The 8 current companies with reported revenue have a combined latest revenue of ₹12,439 Cr; the largest is Jubilant Pharmova Limited at ₹8,346 Cr (FY 2026). Earlier, Shirish Gundopant Belapure was a Director at Albert David Ltd (2019–2025) and Director at Windlas Healthcare Private Limited (2019–2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Mar 2023 | 1978 | ₹8,346 Cr (FY 2026) | Active | |
| Director | 01 Apr 2022 | 2005 | ₹1,637 Cr (FY 2026) | Active | |
| Director | 04 Jan 2025 | 2004 | ₹1,202 Cr (FY 2025) | Active | |
| Additional Director | 29 Dec 2025 | 2020 | ₹622 Cr (FY 2025) | Active | |
| Director | 20 Jun 2024 | 2013 | ₹327 Cr (FY 2023) | Active | |
| Director | 10 Aug 2022 | 1993 | ₹170 Cr (FY 2025) | Active | |
| Partner | 01 Jul 2020 | 2020 | ₹79.26 Cr (FY 2023) | Active | |
| Director | 22 Oct 2020 | 2020 | ₹55.25 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Feb 2019 | 1938 | ₹420 Cr (FY 2024) | Active | |
| Director | 18 Mar 2019 | 2010 | ₹24.17 Cr (FY 2020) | Amalgamated | |
| Managing Director | 16 Jul 2008 | 2005 | ₹431 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shirish Gundopant Belapure
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shirish Gundopant Belapure
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shirish Gundopant Belapure
Shirish Gundopant Belapure currently holds 9 directorships: Jubilant Pharmova Limited (Director, since 07 Mar 2023, revenue ₹8,346 Cr (FY 2026)); Innova Captab Limited (Director, since 01 Apr 2022, revenue ₹1,637 Cr (FY 2026)); Corona Remedies Limited (Director, since 04 Jan 2025, revenue ₹1,202 Cr (FY 2025)); New Life Medicals Private Limited (Additional Director, since 29 Dec 2025, revenue ₹622 Cr (FY 2025)); Jubilant Generics Limited (Director, since 20 Jun 2024, revenue ₹327 Cr (FY 2023)); and 4 more.
Shirish Gundopant Belapure was first appointed on 16 Jul 2008 as Managing Director at Zydus Hospira Oncology Private Limited. The most recent appointment on record is 29 Dec 2025 at New Life Medicals Private Limited.
The 8 current companies of Shirish Gundopant Belapure that report revenue have a combined latest revenue of ₹12,439 Cr: Jubilant Pharmova Limited ₹8,346 Cr (FY 2026); Innova Captab Limited ₹1,637 Cr (FY 2026); Corona Remedies Limited ₹1,202 Cr (FY 2025); New Life Medicals Private Limited ₹622 Cr (FY 2025); Jubilant Generics Limited ₹327 Cr (FY 2023); and 3 more.
Shirish Gundopant Belapure held 3 earlier board appointments: Albert David Ltd (Director, 14 Feb 2019 to 10 Mar 2025); Windlas Healthcare Private Limited (Director, 18 Mar 2019 to 30 Apr 2020); Zydus Hospira Oncology Private Limited (Managing Director, 16 Jul 2008 to 31 Dec 2018).
The current boards of Shirish Gundopant Belapure's companies include Arjun Shanker Bhartia (Jubilant Pharmova Limited), Arun Seth (Jubilant Pharmova Limited), Ashish Omprakash Mukkirwar (Jubilant Pharmova Limited), Hari Shanker Bhartia (Jubilant Pharmova Limited), Harsh Mahajan (Jubilant Pharmova Limited), Naresh Kapoor (Jubilant Pharmova Limited), among others.